Johnson & Johnson (JNJ) Stock Price Drivers

Stock Price Drivers Emerging Markets Emerging markets are a key growth area for pharmaceutical companies, as they are expanding faster as compared to the US market. Medical devices is the best performing segment in emerging markets, and revenues from the segment are expected to grow between 9-11% every year over 2012-2017. YoY Revenue Growth: Emerging Markets vs US -Emerging Market -United States 15% 10% 5% 0% -5% -10% FY08 FY09 FY10 FY11 FY12 SOURCES: Company Data, SEC filings, Bloomberg Professional Services BIDNESS Etc. DISCLAIMER: Bidness Etc(TM) and related marks are owned by Bidness Etc. Any other trademarks appearing on this website are the property of their respective owners and are not used to indicate the origin of goods or services offered or provided by Bidness Etc herein or to suggest approval for or affiliation with Bidness Etc.